Search for Clinical Trial Results

Sponsored By

Dysgerminoma - 7 Studies Found

Status Study
Completed Study Name: Darbepoetin Alfa in Patients With "Poor Prognosis" Germ Cell Tumor Treated With High-Dose Chemotherapy (HD-VIP)
Condition: Dysgerminoma
Date: 2005-09-13
Interventions: Drug: Darbepoetin alfa
Recruiting Study Name: Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors
Condition:
  • Germ Cell Tumor
  • Nonseminomatous Germ Cell Tumor
  • Seminoma Date: 2017-05-16
    Interventions:
    • Drug: Durvalumab 1500 mg by IV
Terminated Study Name: Imatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testicular or Ovarian Cancer
Condition:
  • Ovarian Dysgerminoma
  • Recurrent Malignant Testicular Germ Cell T
    Date: 2002-08-05
    Interventions:
    • Drug: imatinib mesylate Given

Active, not recruiting Study Name: Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
Condition:
  • Cognitive Side Effects of Cancer Therapy
  • Malignant Ovarian Epithelial Tumor
  • Procedure: Cognitive Assessment

Completed Study Name: Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors
Condition:
  • Brain and Central Nervous System Tumors
  • Extragonadal Germ Cell Tumor
  • Biological: pegfilgrastim
  • Drug: cisplatin
Completed Study Name: Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment
Condition:
  • Extragonadal Germ Cell Tumor
  • Ovarian Cancer
  • Teratoma

    • Date: 2007-03-27
    Interventions: Drug: sunitinib malate
Completed Study Name: Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors
Condition:
  • Bladder Cancer
  • Brain and Central Nervous System Tumors
  • Bre
    Date: 2006-04-11
    Interventions:
    • Drug: lapatinib Other Names: